John H Fetting

Associate Professor

1973 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Adjuvant Chemotherapy Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Anticipatory Vomiting Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Nausea Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1973 2018

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Santa-Maria, C., Bardia, A., Blackford, A. L., Snyder, C., Connolly, R., Fetting, J. H., Hayes, D. F., Jeter, S. C., Miller, R. S., Nguyen, A., Quinlan, K., Rosner, G., Slater, S., Storniolo, A. M., Wolff, A. C., Zorzi, J., Henry, N. L. & Stearns, V., May 11 2018, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-9 9 p.

Research output: Contribution to journalArticle

zoledronic acid
Aromatase Inhibitors

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer

Litvak, A., Batukbhai, B., Russell, S. D., Tsai, H. L., Rosner, G., Jeter, S. C., Armstrong, D. K., Emens, L. A., Fetting, J. H., Wolff, A. C., Silhy, R., Stearns, V. & Connolly, R., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Breast Neoplasms
Confidence Intervals
Stroke Volume

Combination epigenetic therapy in advanced breast cancer with 5-azacitidine and entinostat: A phase II national cancer institute/stand up to cancer study

Connolly, R., Li, H., Jankowitz, R. C., Zhang, Z., Rudek-Renaut, M., Jeter, S. C., Slater, S. A., Powers, P., Wolff, A. C., Fetting, J. H., Brufsky, A., Piekarz, R., Ahuja, N., Laird, P. W., Shen, H., Weisenberger, D. J., Cope, L., Herman, J. G., Somlo, G., Garcia, A. A. & 5 othersJones, P. A., Baylin, S. B., Davidson, N. E., Zahnow, C. & Stearns, V., Jun 1 2017, In : Clinical Cancer Research. 23, 11, p. 2691-2701 11 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Breast Neoplasms
Triple Negative Breast Neoplasms

Optimizing the use of gene expression profiling in early-stage breast cancer

Kim, H. S., Cimino-Mathews, A. M., Maria, C. F. M., Umbricht, C. B., Illei, P. B., Cho, S., Chowdhury, N., Pesce, C., Jeter, S. C., Mylander, C., Rosman, M., Tafra, L., Turner, B. M., Hicks, D. G., Jensen, T. A., Miller, D. V., Armstrong, D. K., Connolly, R., Fetting, J. H., Miller, R. S. & 5 othersPark, B. H., Stearns, V., Visvanathan, K., Wolff, A. C. & Cope, L., Dec 20 2016, In : Journal of Clinical Oncology. 34, 36, p. 4390-4397 8 p.

Research output: Contribution to journalArticle

Gene Expression Profiling
Breast Neoplasms
Decision Making

TBCRC 008: Early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer

Connolly, R., Leal, J. P., Goetz, M. P., Zhang, Z., Zhou, X. C., Jacobs, L., Mhlanga, J., Joo, H. O., Carpenter, J., Storniolo, A. M., Watkins, S., Fetting, J. H., Miller, R. S., Sideras, K., Jeter, S. C., Walsh, B., Powers, P., Zorzi, J., Boughey, J. C., Davidson, N. E. & 6 othersCarey, L. A., Wolff, A. C., Khouri, N. F., Gabrielson, E., Wahl, R. L. & Stearns, V., Jan 1 2015, In : Journal of Nuclear Medicine. 56, 1, p. 31-37 7 p.

Research output: Contribution to journalArticle

Fluorodeoxyglucose F18
Breast Neoplasms